Biology as technology will re-invent trillion dollar industries and enhance human and planetary evolution. In this session, two early-stage investors and company builders, Arvind Gupta and Ursheet Parikh, will be in conversation with a leading author and seed investor Po Bronson, Managing Director of IndieBio. They will share their playbook on scaling start-ups touching upon three seminal areas which influence trajectory – fundraising, hiring, and product design. Their insights will draw on their experience with companies including ingredients-as-service leader Geltor which raised a $91 million Series B in 2020, CRISPR platform Mammoth Biosciences whose dream team includes co-founder Nobel Laureate Jennifer Doudna, and Endpoint Health, started by the founding team of GeneWEAVE (acquired by Roche) and former YC Bio Partner Diego Rey, which is designing a new class of therapeutic products that focus on hospital conditions that kill as many people as cancer.